Competitive Advantages
- Potential treatment for neurodegenerative diseases
- Hsp22 overexpression does not alter tau levels or tau phosphorylation status
- Hsp22 overexpression improved reversal spatial learning thus preserves learning and memory
Summary
Tau is a microtubule associated protein that has been linked to multiple neurodegenerative diseases, the most prevalent being Alzheimer’s disease (AD).In AD and other tauopathies, tau pathogenically aggregates, which contributesto the pathogenicity of the disease. Smallheat shock proteins (sHsp) are highly conserved, are highly expressed and respond quickly to stressful conditions. These sHsps have been shown to have increased expression with aging and to directly interact with autophagy-related proteins and to form complexes that help regulate aberrant proteins in the cell. Thismethod investigatesthe effects of Hsp22 wild-type and Hsp22 phosphomimetic mutant over expressionin the brains of tau transgenic miceon tau accumulation, cognitive function, synaptic plasticity, and neuronal health.The results show administration of both wild type Hsp22 and a mutant phosphomimetic Hsp22 were found to increase synaptic plasticity and long term potentiatingthus leading to increases in cognition, learning and memory in patients having a tauopathy such as Alzheimer’s disease.
The images showsthat Hsp22 over expression improvedreversal spatial learning in rTg4510 mice where mtHsp22 over expression significantly lowered the number of errors in rTg4510 mice compared to GFP controls, and mice with wtHsp22 over expression showed fewer errors than GFP controls.
Desired Partnerships
- License
- Sponsored Research
- Co-Development